Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Central Nervous System Disease

5,7-dihydroxytryptamine has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bervoets, K; Millan, MJ; Rivet, JM1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Central Nervous System Disease

ArticleYear
5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:1

    Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Monoamines; Brain; Central Nervous System Diseases; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Methoxydimethyltryptamines; Neurons; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Synapses; Tail

1993